- Report
- September 2024
- 154 Pages
Global
From €2676EUR$2,990USD£2,338GBP
- Report
- July 2023
- 215 Pages
Global
From €3234EUR$3,613USD£2,825GBP
€3804EUR$4,250USD£3,323GBP
- Report
- May 2024
- 133 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- March 2025
- 147 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- February 2025
- 140 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 138 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 128 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 136 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 129 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 140 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 133 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 134 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 129 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 138 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 139 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 133 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 129 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 128 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- May 2024
- 135 Pages
Global
From €3580EUR$3,999USD£3,127GBP
- Report
- February 2026
- 200 Pages
Germany
From €2676EUR$2,990USD£2,338GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more